Thanks to a $30 per share acquisition offer from Stryker Corporation (SYK 0.23%) in September, shares of MAKO Surgical (MAKO +0.00%) are unsurprisingly trading near 52-week-highs.
To be sure, that's great for anyone who bought MAKO Surgical over the past year before the announcement. But unless you're waiting to sell to take advantage of lower long-term capital gains taxes, it doesn't look like a great idea to continue holding your shares at this point, says Fool contributor Steve Symington in the following video.
To understand why, and to hear some good alternatives for putting your hard-earned money back to work, check out the video below to get Steve's full take.
